10-Q/A 1 h04509e10vqza.htm CORE LABORATORIES N.V.- AMENDMENT - 03/31/2002 e10vqza
Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

(Mark One)

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2002

OR

o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the transition period from                      to                     

Commission File Number 001-14273

CORE LABORATORIES N.V.
(Exact name of registrant as specified in its charter)

     
The Netherlands
(State of other jurisdiction of
incorporation or organization)
  Not Applicable
(I.R.S. Employer Identification No.)
     
Herengracht 424
1017 BZ Amsterdam
The Netherlands

(Address of principal executive offices)
  Not Applicable
(Zip Code)

Registrant’s telephone number, including area code: (31-20) 420-3191

     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

     Yes  X   No      

     The number of common shares of the Registrant, par value EUR 0.01 per share, outstanding at May 13, 2002 was 33,240,821.



 


CONSOLIDATED BALANCE SHEETS
CONSOLIDATED STATEMENTS OF OPERATIONS
CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
QUANTITATIVE AND QUALITATIVE DISCLOSURES OF MARKET RISK
PART II — OTHER INFORMATION
Item 1. Legal Proceedings.
Item 2. Changes in Securities.
Item 3. Defaults Upon Senior Securities.
Item 4. Submission of Matters to a Vote of Security Holders.
Item 5. Other Information.
Item 6. Exhibits and Reports on Form 8-K.
SIGNATURE
CERTIFICATION


Table of Contents

CORE LABORATORIES N.V.
FORM 10-Q/A FOR THE QUARTER ENDED MARCH 31, 2002

INDEX

             
        Page
       
Part I — Financial Information
       
 
Item 1 — Financial Statements
       
   
Consolidated Balance Sheets at March 31, 2002 and December 31, 2001
    1  
   
Consolidated Statements of Operations for the Three Months Ended March 31, 2002 and 2001
    2  
   
Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2002 and 2001
    3  
   
Notes to Consolidated Financial Statements
    4  
 
Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations
    11  
 
Item 3 — Quantitative & Qualitative Disclosures of Market Risk
    17  
Part II — Other Information
       
 
Item 1 — Legal Proceedings
    18  
 
Item 2 — Changes in Securities
    18  
 
Item 3 — Defaults Upon Senior Securities
    18  
 
Item 4 — Submission of Matters to a Vote of Security Holders
    18  
 
Item 5 — Other Information
    18  
 
Item 6 — Exhibits and Reports on Form 8-K
    18  
Signature
    19  

ii

 


Table of Contents

EXPLANATORY NOTE

     Core Laboratories N.V. (“Core Laboratories”, “we”, “our” or “us”) is filing this amendment to its Quarterly Report on Form 10-Q for the quarter ended March 31, 2002 to reflect the restatement of certain previously reported information. Portions of Part I, Item 1 “Financial Statements” and Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” have been amended to reflect this restatement. The remaining information in this amended Form 10-Q has not been updated to reflect any changes in information that may have occurred subsequent to the date of the reporting period to which this Form 10-Q relates. Additional information relating to the restatement is contained in Note 8 of the Notes to the Consolidated Financial Statements.

iii

 


Table of Contents

CORE LABORATORIES N.V.
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)

                         
            March 31,   December 31,
            2002   2001
           
 
            (Unaudited)
            (Restated)        
            Note 8        
ASSETS
               
CURRENT ASSETS:
               
 
Cash and cash equivalents
  $ 15,196     $ 14,456  
 
Accounts receivable, less allowance for doubtful accounts of $9,322 and $7,829 in 2002 and 2001, respectively
    93,826       104,933  
 
Inventories
    39,234       41,109  
 
Prepaid expenses and other
    12,293       9,728  
 
Deferred tax asset
    9,464       9,123  
 
   
     
 
     
Total current assets
    170,013       179,349  
PROPERTY, PLANT AND EQUIPMENT, net
    96,276       97,615  
INTANGIBLES AND GOODWILL, net
    135,285       151,257  
OTHER LONG-TERM ASSETS
    11,123       11,279  
 
   
     
 
       
Total assets
  $ 412,697     $ 439,500  
 
   
     
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
CURRENT LIABILITIES:
               
   
Current maturities of long-term debt
  $ 455     $ 454  
   
Accounts payable
    15,941       19,721  
   
Other accrued expenses
    13,383       19,832  
 
   
     
 
       
Total current liabilities
    29,779       40,007  
LONG-TERM DEBT
    94,000       95,089  
OTHER LONG-TERM LIABILITIES
    28,803       27,983  
MINORITY INTEREST
    761       815  
SHAREHOLDERS’ EQUITY:
               
 
Preference shares, EUR 0.01 par value; 3,000,000 shares authorized, no shares issued or outstanding
           
 
Common shares, EUR 0.01 par value; 100,000,000 shares authorized, 33,233,571 and 33,204,571 issued and outstanding in 2002 and 2001, respectively
    546       546  
 
Additional paid-in capital
    186,957       186,751  
 
Retained earnings
    71,851       88,309  
 
   
     
 
       
Total shareholders’ equity
    259,354       275,606  
 
   
     
 
       
   Total liabilities and shareholders’ equity
  $ 412,697     $ 439,500  
 
 
   
     
 

The accompanying notes are an integral part of these consolidated financial statements.

1


Table of Contents

CORE LABORATORIES N.V.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)

                     
        Three Months Ended
        March 31,
       
        2002   2001
       
 
        (Unaudited)
        (Restated)
Note 8
       
SERVICES
  $ 69,178     $ 73,525  
SALES
    15,105       17,821  
 
   
     
 
 
    84,283       91,346  
OPERATING EXPENSES:
               
 
Cost of services
    57,120       56,424  
 
Cost of sales
    13,864       15,076  
 
General and administrative expenses
    4,728       3,560  
 
Depreciation and amortization
    4,922       4,385  
 
Goodwill amortization
          1,033  
 
Other income, net
    1,270       398  
 
   
     
 
 
    81,904       80,876  
INCOME FROM OPERATIONS
    2,379       10,470  
INTEREST EXPENSE
    1,976       1,978  
 
   
     
 
INCOME BEFORE INCOME TAX EXPENSE AND CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE
    403       8,492  
INCOME TAX EXPENSE
    169       2,378  
 
   
     
 
INCOME BEFORE CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE
    234       6,114  
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE
    (16,692 )      
 
   
     
 
NET (LOSS) INCOME
  $ (16,458 )   $ 6,114  
 
   
     
 
PER SHARE INFORMATION:
               
 
BASIC EARNINGS PER SHARE BEFORE CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE
  $ 0.01     $ 0.19  
 
   
     
 
 
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE
  $ (0.50 )   $  
 
   
     
 
   
BASIC (LOSS) EARNINGS PER SHARE
  $ (0.49 )   $ 0.19  
 
   
     
 
 
WEIGHTED AVERAGE BASIC COMMON SHARES OUTSTANDING
    33,210       32,885  
 
   
     
 
 
DILUTED EARNINGS PER SHARE BEFORE CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE
  $ 0.01     $ 0.18  
 
   
     
 
 
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE
  $ (0.50 )   $  
 
   
     
 
   
DILUTED (LOSS) EARNINGS PER SHARE
  $ (0.49 )   $ 0.18  
 
   
     
 
 
WEIGHTED AVERAGE DILUTED COMMON SHARES OUTSTANDING
    33,210       33,958  
 
   
     
 

The accompanying notes are an integral part of these consolidated financial statements.

2


Table of Contents

CORE LABORATORIES N.V.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

                         
            Three Months Ended
            March 31,
           
            2002   2001
           
 
            (Unaudited)
            (Restated)
Note 8
       
CASH FLOWS FROM OPERATING ACTIVITIES:
               
       
Net cash provided by operating activities
    $5,736       $8,366  
 
   
     
 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
 
Capital expenditures
    (4,013 )     (5,411 )
 
Proceeds from sale of fixed assets
    299       22  
 
Other
    (467 )     15  
 
   
     
 
     
Net cash used in investing activities
    (4,181 )     (5,374 )
 
   
     
 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
 
Payments of long-term debt
    (5,014 )     (3,087 )
 
Borrowings under long-term debt
    4,002        
 
Capital lease obligation, net
    (8 )     (88 )
 
Exercise of stock options
    206       1,422  
 
Other
    (1 )     (29 )
 
   
     
 
     
Net cash used in financing activities
    (815 )     (1,782 )
 
   
     
 
NET INCREASE IN CASH AND CASH EQUIVALENTS
    740       1,210  
CASH AND CASH EQUIVALENTS, beginning of period
    14,456       12,519  
 
   
     
 
CASH AND CASH EQUIVALENTS, end of period
  $ 15,196     $ 13,729  
   
 
   
     
 

The accompanying notes are an integral part of these consolidated financial statements.

3


Table of Contents

CORE LABORATORIES N.V.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

     The accompanying unaudited consolidated financial statements include the accounts of Core Laboratories N.V. and have been prepared in accordance with United States of America (“U.S.”) generally accepted accounting principles (“GAAP”) for interim financial information using the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three-month period ended March 31, 2002 are not necessarily indicative of the results that may be expected for the year ending December 31, 2002. Balance sheet information as of December 31, 2001 was derived from the 2001 annual audited financial statements. These financial statements should be read in conjunction with the financial statements and the summary of significant accounting policies and notes thereto included in our Form 10-K for the year ended December 31, 2001.

Recent Pronouncements

     In June 2001, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standard (“SFAS”) 143, “Accounting for Asset Retirement Obligations.” SFAS 143 addresses financial accounting and reporting for obligations associated with the retirement of long-lived assets and the associated asset retirement costs. SFAS 143 requires that the fair value of a liability associated with an asset retirement be recognized in the period in which it is incurred if a reasonable estimate of fair value can be made. The associated retirement costs are capitalized as part of the carrying amount of the long-lived asset and subsequently depreciated over the life of the asset. SFAS 143 will be effective for fiscal years beginning after December 31, 2002. We do not expect SFAS 143 to have a material adverse effect on our financial position or results of operations.

     In August 2001, the FASB issued SFAS 144, “Accounting for the Impairment or Disposal of Long-Lived Assets.” SFAS 144 addresses the financial accounting and reporting for the impairment or disposal of long-lived assets. SFAS 144 supersedes SFAS 121, “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed of.” SFAS 144 provides updated guidance concerning the recognition and measurement of an impairment loss for certain types of long-lived assets and modifies the accounting and reporting of discontinued operations. SFAS 144 is effective for fiscal years beginning after December 31, 2001. We do not expect SFAS 144 to have a material adverse effect on our financial position or results of operations.

     In November 2001, the Emerging Issues Task Force (“EITF”) staff issued Topic D-103, “Income Statement Characterization of Reimbursements Received for “Out-of-Pocket” Expenses Incurred.” As a result, customer reimbursements, including those relating to travel and other out-of-pocket expenses and other similar third-party costs, will be required to be included as revenues effective January 1,

4


Table of Contents

2002, and an equivalent amount of reimbursable expenses will be included in expenses. We do not expect EITF Topic D-103 to have an impact on our financial position or results of operations.

2. INVENTORIES

     Inventories consist of manufactured goods, materials and supplies used for sales or services provided to customers. Inventories are stated at the lower of average or standard cost (includes direct material, labor and overhead) or estimated net realizable value, and are reflected net of valuation reserves of $916,135 and $1,847,000 at March 31, 2002 and December 31, 2001. Respectively, inventories consisted of the following (in thousands):

                   
      March 31,   December 31,
      2002   2001
     
 
      (Unaudited)        
      (Restated)        
      Note 8        
Finished goods
  $ 28,697     $ 30,120  
Parts and materials
    6,433       6,561  
Work in process
    4,104       4,428  
 
   
     
 
 
Total inventories
  $ 39,234     $ 41,109  
 
   
     
 

3. BUSINESS COMBINATIONS, INTANGIBLES AND GOODWILL

     Intangibles include patents, trademarks, service marks and trade names. Goodwill represents the excess of purchase price over the value of the net assets and individual intangibles acquired in acquisitions accounted for as purchases. Intangibles are charged to expense in equal amounts over their estimated useful lives.

     In June 2001, the FASB issued two statements, SFAS 141, “Business Combinations”, and SFAS 142, “Goodwill and Other Intangible Assets”, that amend Accounting Principles Board (“APB”) Opinion No. 16, “Business Combinations”, and supersede APB Opinion No. 17, “Intangible Assets.” SFAS 141 eliminates the pooling-of-interests method of accounting for business combinations and establishes the purchase method of accounting as the only acceptable method on all business combinations initiated after June 30, 2001. Goodwill resulting from a business combination after June 30, 2001 was recognized as an asset but not amortized, while goodwill existing at June 30, 2001 was amortized through December 31, 2001. Beginning January 1, 2002, we no longer amortize goodwill but will test for impairment annually or more frequently if circumstances indicate a potential impairment. We determined our reporting unit level to be our operating units. Using the discounted cash flow method under the requirements of SFAS 142, we have reflected impairment of goodwill of approximately $16.7 million related to our Reservoir Management Segment as a result of adoption of SFAS 142 on January 1, 2002. This impairment is reflected in the statement of operations as a cumulative effect of change in accounting principle. The cessation of goodwill amortization under the guidelines will result in a reduction of approximately $4.2 million in annual operating expenses, assuming no additional impairment of goodwill. The components of intangibles and goodwill are as follows:

5


Table of Contents

                               
          Original                
          Life   March 31,   December 31,
          in Years   2002   2001
              (Restated)    
         
 
 
                  Note 8
(Unaudited)
       
                  (in thousands)
Acquired trade secrets
    5     $ 165     $ 165  
Acquired patents, trademarks and trade names
    10-20       4,973       4,944  
Acquired trade name
    40       4,730       4,704  
 
           
     
 
 
Total intangibles
            9,868       9,813  
 
           
     
 
 
Total goodwill
            142,661       160,728  
 
           
     
 
   
Total intangibles and goodwill
            152,529       170,541  
Less — accumulated amortization
            17,244       19,284  
 
           
     
 
     
Net intangibles and goodwill
          $ 135,285     $ 151,257  
 
           
     
 

4. LONG-TERM DEBT

     Long-term debt is summarized in the following table (in thousands):

                     
        March 31,   December 31,
        2002   2001
       
 
        (Unaudited)        
Credit Facility with a bank group:
               
 
$100,000 revolving debt facilities
  $ 19,000     $ 20,000  
Senior Notes
    75,000       75,000  
Other indebtedness
    455       543  
 
   
     
 
   
Total debt
    94,455       95,543  
Less — current maturities
    455       454  
 
   
     
 
   
Total long-term debt
  $ 94,000     $ 95,089  
 
   
     
 

     In July 1999, we entered into a $100 million Credit Facility which provides for (i) a committed revolving debt facility of $95 million and (ii) a Netherlands guilder denominated revolving debt facility with U.S. dollar equivalency of $5 million. At March 31, 2002, approximately $81 million was available for borrowing under the revolving credit facility. Loans under the Credit Facility bear interest from LIBOR plus 1.25% to a maximum of LIBOR plus 1.75%. The average interest rate in effect at March 31, 2002 was 3.51% and the average for 2002 was 3.33%. The revolving credit facilities require interest payments only, until maturity in June 2004.

     In July 1999, we issued $75 million in Senior Notes which bear an average interest rate of 8.16% and require annual principal payments beginning in July 2005 and continuing through July 2011.

     The terms of the Credit Facility and Senior Notes require us to meet certain financial covenants, including certain minimum equity and cash flow tests. We believe that we are in compliance with all such covenants contained in our credit agreements. All of our material wholly owned subsidiaries are guarantors or co-borrowers under both credit agreements.

6


Table of Contents

5. RESTRUCTURING CHARGES

     During the fourth quarter of 2001, we had several transactions which impacted certain operations that were not viewed as ongoing. We restructured certain operations in Mexico, the United Kingdom, the U.S. and other countries to improve operating efficiencies. This restructuring expense included write-offs of assets and leasehold improvements, and an accrual for facility restoration, severance benefits and lease termination costs. Approximately 100 field employees were terminated. During 2002, we intend to relocate one of our operations from Dallas to the Houston Advanced Technology Center and another facility from Mexico City, Mexico to Villahermosa, Mexico. This charge of approximately $3.0 million affected each of our operating segments as follows: Reservoir Description — $0.8 million; Production Enhancement — $0.1 million; Reservoir Management — $2.1 million. Substantially all employee terminations were completed by the end of the first quarter of 2002. Total cash required for this restructuring charge of $2.1 million will be funded from operating activities. Cash required for the costs incurred through March 31, 2002 was $0.9 million. This charge is summarized in the following table:

Restructuring Charges

(in thousands)

                                                 
    Lease                   Asset                
    Obligations   Severance   Restoration   Write-offs1   Other   Total
   
 
 
 
 
 
Total restructuring charges
  $ 598     $ 951     $ 380     $ 862     $ 184     $ 2,975  
Less: Costs incurred through December 31, 2001
    38       394             862       40       1,334  
 
   
     
     
     
     
     
 
Accrual remaining at December 31, 2001
    560       557       380             144       1,641  
Less: Costs incurred through March 31, 2002 (unaudited)
    40       355                         395  
 
   
     
     
     
     
     
 
Accrual remaining at March 31, 2002 (unaudited)
  $ 520     $ 202     $ 380     $     $ 144     $ 1,246  
 
   
     
     
     
     
     
 

1) The fixed assets and leasehold improvements were disposed of by the end of December 2001. The write-off approximates the carrying amount as these assets were abandoned or sold for salvage value. Depreciation expense was reduced by approximately $20 in 2001, and will be reduced by $82 in 2002 and $281 thereafter. The asset write-offs of $862 were attributable to the Reservoir Management segment.

6. SEGMENT REPORTING

     Our business units have been aggregated into three complementary segments which provide products and services for improving reservoir performance and increasing oil and gas recovery from new and existing fields.

    Reservoir Description: Encompasses the characterization of petroleum reservoir rock, fluid and gas samples. We provide analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry.
 
    Production Enhancement: Includes products and services relating to reservoir well completions, perforations, stimulations and production. We provide integrated services to evaluate the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.

7


Table of Contents

    Reservoir Management: Combines and integrates information from reservoir description and production enhancement services to increase production and improve recovery of oil and gas from our clients’ reservoirs.

Segment Analysis

     We manage our business segments separately due to the different technologies each segment utilizes and requires. Results of these segments are presented below using the same accounting policies as used to prepare the Consolidated Balance Sheets and Statements of Operations. We evaluate performance based on income or loss from operations before income tax, interest and other non-operating income (expense). Summarized financial information concerning our segments is shown in the following table (in thousands):

                   
      Three Months Ended March 31,
     
      2002   2001
      (Restated)
Note 8
   
     
 
      (Unaudited)
Revenues
               
Reservoir Description
  $ 49,479     $ 48,166  
Production Enhancement
    23,402       26,759  
Reservoir Management
    11,402       16,421  
 
   
     
 
 
Consolidated
  $ 84,283     $ 91,346  
 
   
     
 
                   
      Three Months Ended March 31,
     
      2002   2001
      (Restated)
Note 8
   
     
 
      (Unaudited)
Income (loss) before interest and taxes
               
Reservoir Description
  $ 3,714     $ 6,116  
Production Enhancement
    554       3,777  
Reservoir Management
    (1,452 )     625  
Corporate and Other 1
    (437 )     (48 )
 
   
     
 
 
Consolidated
  $ 2,379     $ 10,470  
 
   
     
 

     1) “Corporate and Other” represents those items that are not directly related to a particular segment.

7. EARNINGS PER SHARE

     We present earnings per share in accordance with SFAS No. 128, “Earnings per Share” which requires dual presentation of both basic and diluted earnings per share on the Consolidated Statement of Operations. Basic earnings per common share is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the net additional shares which would be issued if all dilutive stock options outstanding were exercised.

8


Table of Contents

     The following table summarizes the calculation of weighted average common shares outstanding used in the computation of earnings per share:

                 
    Three Months Ended March 31,
(unaudited)
   
    2002   2001
   
 
Weighted average basic common shares outstanding
    33,209,793       32,885,031  
Effect of dilutive stock options 1
          1,073,061  
 
   
     
 
Weighted average diluted common shares outstanding
    33,209,793       33,958,092  
 
   
     
 

1) Options totaling 2,847,321 and 14,676 equivalent common shares were not included in the computation of weighted average diluted common shares for the three months ended March 31, 2002, and 2001, respectively, because the impact of these options was anti-dilutive.

8. RESTATEMENT OF FINANCIALS

     We have restated our previously reported Consolidated Balance Sheet as of March 31, 2002 and our Consolidated Statement of Operations and Consolidated Statement of Cash Flows for the three months ended March 31, 2002. In connection with our 2002 year-end audit, we determined that certain items of revenues and expenses had been accounted for in the incorrect quarter. The following table summarizes the impact and explanation of the adjustments on our previously reported quarterly results (in thousands):

                         
    Three Months Ended        
    March 31, 2002        
    (Unaudited)        
   
       
    Previously                
    Reported   Restated        
   
 
       
Service and sales revenues
  $ 85,064     $ 84,283  a        
Cost of services and sales
    68,938       70,984  b,c        
Other operating expenses
    9,975       10,920  d,e,f        
 
   
     
         
Operating income
    6,151       2,379          
Interest expense
    1,968       1,976          
 
   
     
         
Income before income tax expense
    4,183       403          
Income tax expense
    1,171       169  g        
 
   
     
         
Income before cumulative effect of change in accounting principle
    3,012       234          
Cumulative effect of change in accounting principle
    (16,692 )     (16,692 )        
 
   
     
         
Net loss
  $ (13,680 )   $ (16,458 )        
 
   
     
         
Per share data:
                       
Basic loss per share
  $ (0.41 )   $ (0.49 )        
 
   
     
         
Weighted average basic common shares outstanding
    33,210       33,210          
 
   
     
         
Diluted loss per share
  $ (0.41 )   $ (0.49 )        
 
   
     
         
Weighted average diluted common shares outstanding
    33,210       33,210          
 
   
     
         

  a.   Adjusts revenues by $781, as a result of untimely processing of credit memos.
 
  b.   Record additional provision for doubtful accounts of $1,562 based on the Company’s historical experience.
 
  c.   Adjustment for cost of sales of $484 as a result of reconciliation of account balances primarily in Mexico and Venezuela.
 
  d.   Record adjustment for expense of $173 to correct depreciation expense based on estimated useful life of related assets.
 
  e.   Additional general and administrative expense of $63 in the first quarter for compensation expense.
 
  f.   Additional expense of $709 for correction of foreign exchange adjustment primarily in Venezuela.
 
  g.   Income tax effect of all adjustments above.

9


Table of Contents

     The following table summarizes the impact of these adjustments on our previously reported quarterly financial position (in thousands):

                 
    March 31, 2002
(Unaudited)
   
    Previously        
    Reported Restated
   

Consolidated Balance Sheets
               
Cash
  $ 15,467     $ 15,196  
Accounts receivable
  $ 95,913     $ 93,826  
Inventories
  $ 39,366     $ 39,234  
Prepaid expenses and other current assets
   $ 12,615      $ 12,293  
Property, plant and equipment, net
   $ 96,305      $ 96,276  
Intangibles, Goodwill and other assets
   $ 146,572      $ 146,408  
Accounts payable
   $ 15,946      $ 15,941  
Other current liabilities
   $ 13,890      $ 13,383  
Other liabilities and minority interest
   $ 29,279      $ 29,564  
Retained earnings
   $ 74,629      $ 71,851  

10


Table of Contents

CORE LABORATORIES N.V.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

General

     This discussion includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. We have based the forward-looking statements relating to our operations on our current expectations, estimates and projections. We caution you that these statements are not guarantees of future performance and involve risks and uncertainties that we cannot predict. In addition, we have based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. Accordingly, our actual outcomes and results may differ materially from what we have expressed or forecast in the forward-looking statements. Our forward-looking statements are based on assumptions that we believe to be reasonable but that may not prove to be accurate. All of our forward-looking information is, therefore, subject to risks and uncertainties that could cause actual results to differ materially from the results expected. Although it is not possible to identify all factors, these risks and uncertainties include the risk factors discussed below.

     Industry risks

     The oil and gas industry is highly cyclical and there are numerous factors affecting the supply of and demand for oil and natural gas, which include:

    market prices of oil and gas;
 
    cost of producing oil and natural gas;
 
    the level of drilling and production activity;
 
    mergers, consolidations and downsizing among our clients;
 
    coordination by the OPEC; and
 
    the impact of commodity prices on the expenditure levels of our customers.

     Business risks

     Our results of operations could be adversely affected by risks and uncertainties in the business environment in which we operate, including:

    competition in our markets;
 
    the realization of anticipated synergies from acquired businesses and future acquisitions;
 
    our ability to continue to develop or acquire new and useful technology; and
 
    interest rates and the cost of capital.

     International risks

     We conduct our business in over 50 countries and are subject to political and economic instability and the laws and regulations in the countries in which we operate. These include:

11


Table of Contents

    global economic conditions;
 
    political actions and requirements of national governments including trade restrictions, and embargos and expropriations of assets;
 
    potential income tax liabilities in multiple jurisdictions;
 
    civil unrest;
 
    fluctuations and changes in currency exchange rates; and
 
    the impact of inflation.

     Other risks

     The events of September 11, the economic downturn and political events that followed and continue to unfold could result in lower demand for our products and services. Our client base could be impacted by events we cannot predict or we could be impacted by a change in the conduct of business, transportation and security measures. In addition we are subject to other risk factors such as the impact of environmental regulations, litigation risks as well as the dependence on the oil and gas industry. Many of these risks are beyond our control. In addition, future trends for pricing, margins, revenues and profitability remain difficult to predict in the industries we serve and under current economic and political conditions. We do not feel obligated to publicly update any of our forward-looking statements.

     Our operations are subject to various risks and other factors including, but not limited to:

    our ability to continue to develop or acquire new and useful technology.
 
    the realization of anticipated synergies from acquired businesses and future acquisitions.
 
    our dependence on the oil and gas industry, and the impact of commodity prices on the expenditure levels of our customers.
 
    competition in our markets.
 
    the risks and uncertainties attendant to adverse industry, political, economic and financial market conditions, including stock prices, government regulations, interest rates and credit availability.

     Core Laboratories was established in 1936 and is one of the world’s leading providers of proprietary and patented reservoir description, production enhancement and reservoir management services to the oil and gas industry. These services are directed toward enabling our clients to improve reservoir performance and increase oil and gas recovery from their producing fields. We have over 70 offices in more than 50 countries and have approximately 4,200 employees.

Results of Operations

     We have restated our previously reported Consolidated Balance Sheet as of March 31, 2002 and our Consolidated Statement of Operations and Consolidated Statement of Cash Flows for the three months ended March 31, 2002. In connection with our 2002 year-end audit, we determined that certain items of revenues and expenses had been accounted for in the incorrect quarter. For additional information about restatements, see Note 8 of the Notes to Consolidated Financial Statements.

12


Table of Contents

     Service revenues for the first quarter of 2002 decreased $4.3 million, or 5.9% from the same period last year, primarily due to decreased worldwide oilfield activities.

     Cost of services expressed as a percentage of service revenue were 83% and 77% in the first quarter of 2002 and the same period last year, respectively. Our relatively fixed cost structure for our services caused our cost of services, in relation to revenues, to rise in the first quarter of 2002 compared to the same time period in the prior year.

     Sales revenues decreased to $15.1 million in the first quarter of 2002 from $17.8 million in the first quarter of 2001, a 15% decrease. This decrease was caused, in most part, to the deep decline in drilling for natural gas in the North American markets. Consequently, there was lower demand for our well completion products.

     Cost of sales in the first quarter of 2002 was 92% of sales revenue as compared to 85% in the same period last year. We have taken further actions, including reducing headcount an additional 15%, in our manufacturing operations in an effort to reduce cost of sales.

     General and administrative expenses are comprised of corporate management and centralized administrative services which benefit our operating subsidiaries. Although general and administrative expenses are generally more fixed in nature as a percentage of revenues, we did experience an increase of $1.2 million in 2002 compared to the prior year which was largely attributable to growth in the number of people necessary to support increases in the scope of our operations. Part of the increase was due to an increase in our direct marketing effort focused on providing integrated solutions to our clients, as well as an increase in staffing levels while continuing implementation of the company-wide financial accounting systems.

     Depreciation and amortization expense for the first quarter of 2002 increased $0.5 million as compared to the corresponding period in 2001. This increase was due to additional capital investments, which include an extension to the new Houston facility.

     As a result of adoption of SFAS 142 beginning January 1, 2002, we no longer amortize goodwill but will test for impairment annually or more frequently if circumstances indicate a potential impairment. Under the requirements, we have reflected impairment of goodwill of approximately $16.7 million related to our Reservoir Management segment. This impairment is reflected in the statement of operations as a cumulative effect of a change in accounting principle. The cessation of goodwill amortization under the guidelines will result in a reduction of approximately $4.2 million in annual operating expenses, assuming no additional impairment of goodwill.

     Included in other income are foreign exchange charges of $1.0 million primarily related to Venezuela.

     The 2002 effective income tax rate increased to 42% of income before cumulative effect of change in accounting principle from the 2001 rate of 28%. This increase is the result of an increase in expenses that are not deductible for tax purposes and an increased valuation allowance on Venezuela deferred tax assets.

     During the fourth quarter of 2001, we had several transactions which impacted certain operations that were not viewed as ongoing. We restructured certain operations in Mexico, the United Kingdom, the U.S. and other countries to improve operating efficiencies. This restructuring expense included

13


Table of Contents

write-offs of assets and leasehold improvements, and an accrual for facility restoration, severance benefits and lease termination costs. Approximately 100 field employees were terminated. During 2002, we intend to relocate one of our operations from Dallas to the Houston Advanced Technology Center and another facility from Mexico City, Mexico to Villahermosa, Mexico. This charge of approximately $3.0 million affected each of our operating segments as follows: Reservoir Description — $0.8 million; Production Enhancement — $0.1 million; Reservoir Management — $2.1 million. Substantially all employee terminations were completed by the end of the first quarter of 2002. Total cash required for this restructuring charge of $2.1 million will be funded from operating activities. Cash required for the costs incurred through March 31, 2002 was $0.9 million. This charge is summarized in the following table:

Restructuring Charges

(in thousands)

                                                 
    Lease                   Asset                
    Obligations   Severance   Restoration   Write-offs1   Other   Total
   
 
 
 
 
 
Total restructuring charges
  $ 598     $ 951     $ 380     $ 862     $ 184     $ 2,975  
Less: Costs incurred through December 31, 2001
    38       394             862       40       1,334  
 
   
     
     
     
     
     
 
Accrual remaining at December 31, 2001
    560       557       380             144       1,641  
Less: Costs incurred through March 31, 2002 (unaudited)
    40       355                         395  
 
   
     
     
     
     
     
 
Accrual remaining at March 31, 2002
  $ 520     $ 202     $ 380     $     $ 144     $ 1,246  
 
   
     
     
     
     
     
 

1) The fixed assets and leasehold improvements were disposed of by the end of December 2001. The write-off approximates the carrying amount as these assets were abandoned or sold for salvage value. Depreciation expense was reduced by approximately $20 in 2001, and will be reduced by $82 in 2002 and $281 thereafter. The asset write-offs of $862 were attributable to the Reservoir Management segment.

Segment Analysis

(in thousands)

                   
      Three Months Ended March 31,
     
      2002   2001
      (Restated)    
     
 
      (Unaudited)
Revenues
               
Reservoir Description
  $ 49,479     $ 48,166  
Production Enhancement
    23,402       26,759  
Reservoir Management
    11,402       16,421  
 
   
     
 
 
Consolidated
  $ 84,283     $ 91,346  
 
   
     
 
                   
      Three Months Ended March 31,
     
      2002   2001
      (Restated)    
     
 
      (Unaudited)
Income (loss) before interest and taxes
               
Reservoir Description
  $ 3,714     $ 6,116  
Production Enhancement
    554       3,777  
Reservoir Management
    (1,452 )     625  
Corporate and Other 1
    (437 )     (48 )
 
   
     
 
 
Consolidated
  $ 2,379     $ 10,470  
 
   
     
 

     1) “Corporate and Other” represents those items that are not directly related to a particular segment.

14


Table of Contents

Reservoir Description

     Revenues from the Reservoir Description segment increased $1.3 million in the first quarter of 2002. Increased international demand for our existing services and deepwater services, as well as the introduction of new technologies into international arenas, bolstered revenue in this segment. Income before interest and taxes decreased by $2.4 million due to decreased margins due to seasonal slowness and the reduced worldwide economic activity causing a negative impact on our crude oil and petroleum product characterization unit.

Production Enhancement

     Revenues from the Production Enhancement segment were $23.4 million in the first quarter of 2002 compared to $26.8 million in the same period in the prior year, a decrease of 13%, due to decreased demand for our well completion and stimulation technologies primarily in North American markets. Income before interest and taxes decreased $3.2 million to $0.6 million, an 85% decrease, again caused by the severity of the reduction in activity. The rig count in North America dropped by 38% compared to the corresponding period in the prior year.

Reservoir Management

     Revenues from the Reservoir Management segment in the first quarter of 2002 were $11.4 million, a decrease of $5.0 million compared to the same period in the prior year due to decreasing activity levels of our clients and our decision not to attain business with unacceptable earnings’ margins.

Liquidity and Capital Resources

     We have historically financed our activities through cash flows from operations, bank credit facilities, equity financing and the issuance of debt.

     During the first quarter of 2002, cash flows from operating activities were $5.7 million, a decrease of $2.6 million from the same period in 2001. At March 31, 2002, we had working capital of $140.2 million and a current ratio of 5.7 to 1.0, compared to working capital of $139.3 million and a current ratio of 4.5 to 1.0 at December 31, 2001. We are a Netherlands holding company and we conduct substantially all of our operations through subsidiaries. Consequently, our cash flow is dependent upon the ability of our subsidiaries to pay cash dividends or otherwise distribute or advance funds to us.

     Our investing activities used $4.2 million in the first quarter of 2002 compared to $5.4 million in the same period in 2001 due to a reduction in our capital expenditure program. Our financing activities used $0.8 million in the first quarter of 2002, and $1.8 million in the same period in 2001.

15


Table of Contents

     Our ability to maintain and grow our operating income and cash flows is dependent upon continued investing activities. We believe our future cash flows from operations, supplemented by our borrowing capacity and issuances of additional equity should be sufficient to fund debt requirements, capital expenditures, working capital and future acquisitions.

16


Table of Contents

CORE LABORATORIES N.V.
QUANTITATIVE AND QUALITATIVE DISCLOSURES OF MARKET RISK

Market Risk

     We are exposed to market risk, which is the potential loss arising from adverse changes in market prices and rates. We do not enter, or intend to enter, into derivative financial instruments for trading or speculative purposes. We do not believe that our exposure to market risks, which are primarily related to interest rate changes and fluctuations in foreign exchange rates, are material. During 1999, we issued fixed rate Senior Notes denominated in U.S. dollars. The proceeds were used to pay off variable rate term loans. This significantly reduced our exposure to market risk. This section should be read in conjunction with “Note 4 — Long-Term Debt” of the Notes to Consolidated Financial Statements.

Interest Rate Risk

     We are exposed to interest rate risk on our Credit Facility debt that carries a variable interest rate. At March 31, 2002, our variable rate debt outstanding of $19.0 million approximated its fair value. A one percent change in the interest rate would not cause a material change in interest expense on an annual basis. We attempt to balance the benefit of variable rate debt that has inherent increased risk with fixed rate debt that has less market risk.

17


Table of Contents

CORE LABORATORIES N.V.
PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

     We are from time to time subject to legal proceedings and claims that arise in the ordinary course of business. We believe that the outcome of current legal actions will not have a material adverse effect upon our consolidated financial position or results of operations.

Item 2. Changes in Securities.

     None

Item 3. Defaults Upon Senior Securities.

     None

Item 4. Submission of Matters to a Vote of Security Holders.

     None

Item 5. Other Information.

     All references to the nominal value of EUR 0.01 (formerly NLG 0.03) of each share in the share capital of Core Laboratories N.V. is made with reference to article 2:67c of the Dutch Civil Code.

Item 6. Exhibits and Reports on Form 8-K.

     (a)  Exhibits

     
10.1   Core Laboratories N.V. 1995 Long Term Incentive Plan (as amended and restated) Employee Bonus Restricted Share Agreement.
10.2   Core Laboratories N.V. 1995 Long Term Incentive Plan (as amended and restated) Executive Share Matching Restricted Share Agreement.
10.3   Core Laboratories N.V. 1995 Long Term Incentive Plan (as amended and restated) Performance Share Award Restricted Share Agreement.
10.4   Third Agreement to Supplemental Executive Retirement Plan (John D. Denson).
10.5   Third Agreement to Supplemental Executive Retirement Plan (Monty L. Davis).
10.6   Third Agreement to Supplemental Executive Retirement Plan (Joseph R. Perna, David M. Demshur, Stephen D. Weinroth and Richard L. Bergmark).

     (b)  Reports on Form 8-K

       During the quarter ended March 31, 2002, we filed Form 8-K, reporting under Item 4 “Change in Registrant’s Certifying Accountant”. The report disclosed the decision to no longer engage Arthur Andersen LLP as our independent public accountants and our appointment of PricewaterhouseCoopers LLP.

18


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant, Core Laboratories N.V., has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
    CORE LABORATORIES N.V.
    by:   Core Laboratories International B.V.
         
         
Dated: May 15, 2002   By:   /s/ Richard L. Bergmark
     
    Richard L. Bergmark
    Chief Financial Officer

19


Table of Contents

CERTIFICATION

I, David M. Demshur, certify that:

1.     I have reviewed this quarterly report on Form 10-Q/A of Core Laboratories N.V.;

2.     Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.     Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.     The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5.     The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

6.     The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

         
Date: April 3, 2003        
 
    By: /s/ David M. Demshur

David M. Demshur
Chief Executive Officer
 

20


Table of Contents

I, Richard L. Bergmark, certify that:

1.     I have reviewed this quarterly report on Form 10-Q/A of Core Laboratories N.V.;

2.     Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3.     Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4.     The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5.     The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

6.     The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

         
Date: April 3, 2003        
 
    By:  /s/ Richard L. Bergmark

Richard L. Bergmark
Chief Financial Officer
 

21